New Triple-Threat attack on aggressive lung cancer
NCT ID NCT06610734
Summary
This study is testing if adding a new immunotherapy drug (adebrelimab) and a low dose of radiation to standard chemotherapy works better for people with advanced small cell lung cancer that has spread. It will involve about 202 patients who haven't had prior treatment for this advanced stage. The main goal is to see if this combination helps people live longer compared to standard care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMALL CELL LUNG CANCER EXTENSIVE STAGE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
West China Hospital of Sichuan University
RECRUITINGSichuan, China
Contact
Conditions
Explore the condition pages connected to this study.